Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Chemmedchem|April 10, 2024
Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer AgentsNishant M Karadkhelkar, Pranav Gupta, Leonard Barasa, et al.Anti-Cancer Agents in Medicinal Chemistry|November 21, 2019
Synthesis and Biological Evaluation of Structurally Diverse Benzimidazole Scaffolds as Potential Chemotherapeutic AgentsLeonard Barasa, Hari P Vemana, Nirupama Surubhotla, et al.International Journal of Biological Sciences|July 30, 2021
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug ResistanceSilpa Narayanan, Zhuo-Xun Wu, Jing-Quan Wang, et al.Frontiers in Oncology|August 22, 2022
Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo studySilpa Narayanan, Qiu-Xu Teng, Zhuo-Xun Wu, et al.Acta Pharmaceutica Sinica. B|June 1, 2022
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo studyZhuo-Xun Wu, Qiu-Xu Teng, Yuqi Yang, et al.Cancer Letters|December 15, 2019
Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemiaPranav Gupta, Guan-Nan Zhang, Anna Maria Barbuti, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 10, 2024
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitorQiu-Xu Teng, Zi-Ning Lei, Jing-Quan Wang, et al.Pageof 3